- Home
- KURA vs HQ Comparison
KURA vs HQ Comparison
Compare KURA & HQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | HQ |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 879.7M |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | KURA | HQ |
|---|---|---|
| Price | $9.83 | $15.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 2 |
| Target Price | ★ $31.85 | $20.50 |
| AVG Volume (30 Days) | ★ 1.6M | 422.6K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $42.46 | N/A |
| Revenue Next Year | $116.75 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $8.29 |
| 52 Week High | $13.90 | $45.00 |
Technical Indicators
Market Signals| Indicator | KURA | HQ |
|---|---|---|
| Relative Strength Index (RSI) | 31.67 | 50.60 |
| Support Level | $8.45 | $13.68 |
| Resistance Level | $11.32 | $16.73 |
| Average True Range (ATR) | 0.42 | 1.21 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 13.92 | 50.00 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About HQ Horizon Quantum Holdings Ltd. Class A Ordinary Shares
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.